REBECCA HOLLOMAN: Open Payments
NPI 1205679008 · LEBANON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 49 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $817 · 2025 $970
Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $238 |
| Boston Scientific Corporation | 7 | $212 |
| Organogenesis Inc. | 4 | $111 |
| Smith+Nephew, Inc. | 3 | $76 |
| Kerecis Limited | 3 | $64 |
| Averitas Pharma Inc. | 2 | $49 |
| PFIZER INC. | 3 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Medtronic, Inc. | 2 | $38 |
Products named: WaveWriter Alpha Prime 16, UBRELVY, PURAPLY WOUND MATRIX, Kerecis SurgiClose, QULIPTA, QUTENZA, NURTEC ODT, JOURNAVX.
Industry payments across IN — which companies pay providers there.
